CELSR2 and central nervous system cancer: In patients with primary and recurrent glioma, the survival probability was negatively correlated with CELSR2 expression in the glioma tissues: patients with higher CELSR2 mRNA levels in the glioma tissues showed a shorter survival time (Fig. 1E, F).